Furthermore, HO-1 inhibition abolishes interleukin-10-mediated improvements in pulmonary hypertension, vascular cell proliferation, right ventricular hypertrophy, and mortality in rats treated with monocrotaline [122]. Here, HMOX1 is linked to pulmonary arterial hypertension.